Annual Report 2024

CONSOLIDATEDSTATEMENT OF PROFIT OR LOSSANDOTHER COMPREHENSIVE INCOME For the year ended 31 December 2024 44 The United Laboratories International Holdings Limited Annual Report 2024 2024 2023 NOTES RMB’000 RMB’000 Revenue 5 13,758,937 13,739,879 Cost of sales (7,676,546) (7,405,042) Gross profit 6,082,391 6,334,837 Other income 6 356,929 212,475 Other gains and losses, net 7 153,781 23,671 Selling and distribution expenses (1,402,483) (1,593,799) Administrative expenses (894,112) (789,859) Research and development expenditures (890,757) (757,248) Other expenses (36,821) (21,138) Impairment losses (recognised) reversed under expected credit loss model, net 9 (44,880) 1,962 Share of results of an associate 21 (192) 143 Finance costs 8 (34,958) (66,896) Profit before taxation 3,288,898 3,344,148 Tax expense 11 (631,077) (643,303) Profit for the year 12 2,657,821 2,700,845 Other comprehensive income Item that may be reclassified subsequently to profit or loss: Exchange differences arising on translation of foreign operations 549 425 Total comprehensive income for the year 2,658,370 2,701,270